New Bayer chairman faces sour investors in his first major tour Details Bayer has lost about a third of its value so far this year EXCERPT: The broadside from multiple shareholders highlights their continued unease with Bayer’s strategy a good two years after the German company bought Monsanto for about $63 billion. That takeover has come to be widely viewed as disastrous because, among other things, it saddled Bayer with massive legal bills tied to Monsanto’s controversial Roundup weedkiller, prompting open rebellion from shareholders against senior management....